Oncotarget

Vol 10, No 42

July 2, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 42 of Oncotarget features Figure 6, "Model for CEMIP-mediated upregulation of BiP leading to increased cell survival during hypoxia/stress," by Banach, et al.

Table of Contents

Editorial

Genetic manipulation of the mammary gland and potential applications

Genetic manipulation of the mammary gland and potential applications

https://doi.org/10.18632/oncotarget.27044

Hiroaki Tagaya, Kentaro Semba,  and Kosuke Ishikawa
4253-4254
PDF  |  How to cite  |  Order a Reprint

Research Papers

Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials

Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials

https://doi.org/10.18632/oncotarget.26981

Jongphil Kim,  and Michael J. Schell
4255-4261
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix

PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix

https://doi.org/10.18632/oncotarget.27008

Minakshi Mann, Sachin Kumar, Shyam S. Chauhan, Neerja Bhatla, Sunesh Kumar, Sameer Bakhshi, Ritu Gupta, Ashok Sharma,  and Lalit Kumar
4262-4275
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting

AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting

https://doi.org/10.18632/oncotarget.26945

Alvin Y. Liu, Adelle D. Kanan, Tomasz P. Radon, Siama Shah, Mark E. Weeks, Julie M. Foster, Jane K. Sosabowski, Laurent Dumartin,  and Tatjana Crnogorac-Jurcevic
4276-4289
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Comparative RNA-seq analysis reveals dys-regulation of major canonical pathways in ERG-inducible LNCaP cell progression model of prostate cancer

Comparative RNA-seq analysis reveals dys-regulation of major canonical pathways in ERG-inducible LNCaP cell progression model of prostate cancer

https://doi.org/10.18632/oncotarget.27019

Parameet Kumar, Joyeeta Chakraborty, Gauthaman Sukumar, Clifton Dalgard, Raghunath Chatterjee,  and Roopa Biswas
4290-4306
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia

https://doi.org/10.18632/oncotarget.27036

Anna Banach, Ya-Ping Jiang, Eric Roth, Cem Kuscu, Jian Cao,  and Richard Z. Lin
4307-4320
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval

https://doi.org/10.18632/oncotarget.27039

Eva Ciruelos, Emilio Alba, Rafael López, Anna Lluch, Miguel Martín, Isabel Arroyo, Beatriz Navarro, David Carcedo, Ramón Colomer,  and Joan Albanell
4321-4332
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reviews

The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications

The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications

https://doi.org/10.18632/oncotarget.27016

Cecilia Söderberg Nauclér, Jürgen Geisler,  and Katja Vetvik
4333-4347
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Corrections

Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB

Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB

https://doi.org/10.18632/oncotarget.27046

Sang Eun Park, Hye Jin Yi, Nayoung Suh, Yun-Yong Park, Jae-Young Koh, Seong-Yun Jeong, Dong-Hyung Cho, Choung-Soo Kim,  and Jung Jin Hwang
4348-4349
Correction  |  PDF  |  How to cite

Correction: Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes

Correction: Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes

https://doi.org/10.18632/oncotarget.27048

Garima Yagnik, Martin Rutkowski, Sumedh S. Shah,  and Manish K. Aghi
4350-4350
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC